Muromonab-cd3 Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.1 Immunomodulators Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Muromonab-cd3 Manufacturers of Muromonab-cd3 Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Muromonab-cd3's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 5 mg5 (5)As recommended.IVOnce a day injected in vein for 10-14 days. Paedriatic Dosage (20kg) 2.5 to 5 mg3.8 (3.75)As recommended.IVIV Injection for 10-14 days due to higher CD3 lymphocytes count the dose required to be titrated upw Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Muromonab-cd3 is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Muromonab-cd3 Back to top Manufacturers of Muromonab-cd3 in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Muromonab-cd3 Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.1 Immunomodulators Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Muromonab-cd3 Manufacturers of Muromonab-cd3 Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Muromonab-cd3's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 5 mg5 (5)As recommended.IVOnce a day injected in vein for 10-14 days. Paedriatic Dosage (20kg) 2.5 to 5 mg3.8 (3.75)As recommended.IVIV Injection for 10-14 days due to higher CD3 lymphocytes count the dose required to be titrated upw Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Muromonab-cd3 is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Muromonab-cd3 Back to top Manufacturers of Muromonab-cd3 in Pakistan Back to top Previous Drug Generic - Next Drug Generic